During the past decade, Dayton Science Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dayton Science Institute" are "Crohn's Disease" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Dayton Science Institute" in a lesser frequency.

Most popular intervention types in "Dayton Science Institute" are "Drug" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "vedolizumab" (2 trials), "MDX-1100" (1 trials), "PROCHYMAL adult human mesenchymal stem cells" (1 trials) and "sterile saline for injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dayton Science Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Dayton Science Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dayton Science Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dayton Science Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".